Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma

Immunotherapy. 2014;6(6):663-6. doi: 10.2217/imt.14.48.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Benzothiazoles / pharmacology
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / immunology*
  • Brain Neoplasms / radiotherapy
  • Chemoradiotherapy
  • Glioblastoma / drug therapy
  • Glioblastoma / immunology*
  • Glioblastoma / radiotherapy
  • Humans
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Macrophages / radiation effects
  • Microglia / drug effects
  • Microglia / immunology*
  • Microglia / radiation effects
  • Picolinic Acids / pharmacology
  • Receptor, Macrophage Colony-Stimulating Factor / antagonists & inhibitors
  • Receptor, Macrophage Colony-Stimulating Factor / immunology
  • Receptor, Macrophage Colony-Stimulating Factor / metabolism
  • Treatment Outcome
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / immunology
  • Tumor Microenvironment / radiation effects

Substances

  • 4-(2-(2-hydroxycyclohexylamino)benzothiazol-6-yloxy)pyridine-2-carboxylic acid methylamide
  • Benzothiazoles
  • Picolinic Acids
  • Receptor, Macrophage Colony-Stimulating Factor